Daiichi Sankyo
Clinical trials sponsored by Daiichi Sankyo, explained in plain language.
A global pharmaceutical company developing medicines, notably in oncology.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for aggressive lung cancer: combo therapy enters human trials Results expected Sep 2026 (estimated)
- New hope for advanced tumors? first human trial of DS-3939a begins Results expected Oct 2026 (estimated)
- Liver impairment study tests cancer drug safety Results expected Oct 2026 (estimated)
- Can a new drug target Hard-to-Treat kidney and ovarian cancers? Results expected Dec 2026 (estimated)
- Can Real-World data confirm T-DXd's promise in HER2-Mutant lung cancer? Results expected Feb 2027 (estimated)
-
Experimental drug for rare skin disease fails to reach goal
Disease control Stopped earlyThis early-stage trial tested a drug called DS-2325a in 9 adults with Netherton syndrome, a rare genetic condition causing severe skin redness, scaling, and allergies. The study aimed to check safety and whether the drug could help control the disease. However, the trial was term…
Phase 1/2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Experimental cancer drug DS-9606a tested in early trial, but stopped early
Disease control Stopped earlyThis early-phase study tested an experimental drug called DS-9606a in 88 people with advanced solid tumors that have a specific protein (Claudin-6). The main goal was to check safety and find the right dose. The trial was terminated, meaning it stopped before completion, so we ha…
Phase 1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC